Jun 23 2021
#2 Daniel Kuritzkes - Monoclonal Antibodies
Daniel Kuritzkes, MDBrigham and Women's Hospital; Harvard Medical School, United StatesConflict of Interest DisclosureReceipt of grants/research support from Atea, Gilead, Merck, and ViiVReceipt of honoraria or consultation fees from Abpro, Atea, Decoy, Gilead, GlaxoSmithKline, Merck, Novartis, Rigel, ViiV